Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association

(2018) Laxmi S. Mehta et al.   CIRCULATION

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

(2018) Annie M. Young et al.   JOURNAL OF CLINICAL ONCOLOGY

Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity

(2018) Mônica Samuel Avila et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

(2018) Gary E. Raskob et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

(2018) Shannon L. Maude et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group

(2017) Johannes J.M. Kwakman et al.   EUROPEAN JOURNAL OF CANCER

Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular Disease

(2017) Arvind K. Pandey et al.   HYPERTENSION

Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition

(2017) Rhian M. Touyz et al.   HYPERTENSION

Identifying models of cancer survivorship care.

(2017) Holly Mead et al.   JOURNAL OF CLINICAL ONCOLOGY

Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity

(2017) Edith Pituskin et al.   JOURNAL OF CLINICAL ONCOLOGY

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

(2017) Martin Dreyling et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2017) Saro H. Armenian et al.   JOURNAL OF CLINICAL ONCOLOGY

Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

(2017) Crystal S. Denlinger et al.   Journal of the National Comprehensive Cancer Network

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

(2017) Paul M Ridker et al.   LANCET

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease

(2017) Siddhartha Jaiswal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

(2017) Andreas Hochhaus et al.   NEW ENGLAND JOURNAL OF MEDICINE

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

(2017) Sattva S. Neelapu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice

(2017) José J. Fuster et al.   SCIENCE

How to Develop a Cardio-Oncology Clinic

(2017) David Snipelisky et al.   Heart Failure Clinics

Long‐Term Outcomes of Patients With Mediastinal Radiation–Associated Severe Aortic Stenosis and Subsequent Surgical Aortic Valve Replacement: A Matched Cohort Study

(2017) Eoin Donnellan et al.   Journal of the American Heart Association

Cardiovascular Toxicities Associated with Cancer Immunotherapies

(2017) Daniel Y. Wang et al.   Current Cardiology Reports

Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies

(2017) Weijuan Li et al.   JAMA Oncology

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade

(2017) Heinz Läubli et al.   Journal for ImmunoTherapy of Cancer

Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

(2016) Torsten Dahlén et al.   ANNALS OF INTERNAL MEDICINE

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas

(2016) A. Patnaik et al.   ANNALS OF ONCOLOGY

Cancer treatment and survivorship statistics, 2016

(2016) Kimberly D. Miller et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors

(2016) Toshihiko Doi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States

(2016) S. M. Bluethmann et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Antithrombotic Therapy for VTE Disease

(2016) Clive Kearon et al.   CHEST

Vascular Toxicities of Cancer Therapies

(2016) Joerg Herrmann et al.   CIRCULATION

Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated With Percutaneous Coronary Intervention

(2016) Grant W. Reed et al.   Circulation-Cardiovascular Interventions

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

(2016) Geeta Gulati et al.   EUROPEAN HEART JOURNAL

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

(2016) Jose Luis Zamorano et al.   EUROPEAN HEART JOURNAL

Targeting T Cell Co-receptors for Cancer Therapy

(2016) Margaret K. Callahan et al.   IMMUNITY

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma

(2016) Frederika A. van Nimwegen et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathology and biology of radiation-induced cardiac disease

(2016) Soile Tapio   JOURNAL OF RADIATION RESEARCH

The epidemiology of venous thromboembolism

(2016) John A. Heit et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

(2016) Douglas B. Johnson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Toxic Effects of Targeted Cancer Therapies

(2016) Javid J. Moslehi   NEW ENGLAND JOURNAL OF MEDICINE

Toxicity and management in CAR T-cell therapy

(2016) Challice L Bonifant et al.   Molecular Therapy-Oncolytics

Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer

(2016) Chau Dang et al.   JAMA Oncology

Cardiac Protection in HER2-Targeted Treatment

(2016) Ana Barac et al.   JAMA Oncology

Changes in blood glucose and cholesterol levels due to androgen deprivation therapy in men with non-metastatic prostate cancer

(2016) Hassanabbas Z. Mohamedali et al.   CUAJ-Canadian Urological Association Journal

Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma

(2015) H. Izzedine et al.   ANNALS OF ONCOLOGY

Cardiovascular Disease in Adult Survivors of Childhood Cancer

(2015) Steven E. Lipshultz et al.   Annual Review of Medicine

Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma

(2015) Sekwon Jang et al.   CANCER

Direct Oral Anticoagulants in Patients With VTE and Cancer

(2015) Maria Cristina Vedovati et al.   CHEST

Cardio-Oncology

(2015) Andrew M. Bellinger et al.   CIRCULATION

Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma

(2015) R. R. McKay et al.   CLINICAL CANCER RESEARCH

Quantifying Observational Evidence for Risk of Fatal and Nonfatal Cardiovascular Disease Following Androgen Deprivation Therapy for Prostate Cancer: A Meta-analysis

(2015) Cecilia Bosco et al.   EUROPEAN UROLOGY

Effect of androgen deprivation therapy on arterial stiffness and serum lipid profile changes in patients with prostate cancer: a prospective study of initial 6-month follow-up

(2015) Ryo Oka et al.   International Journal of Clinical Oncology

Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer

(2015) Agnes Y. Y. Lee et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia

(2015) Javid J. Moslehi et al.   JOURNAL OF CLINICAL ONCOLOGY

Vascular and Metabolic Implications of Novel Targeted Cancer Therapies

(2015) Weijuan Li et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular Health of Patients With Cancer and Cancer Survivors

(2015) Ana Barac et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Abnormal Exercise Response in Long-Term Survivors of Hodgkin Lymphoma Treated With Thoracic Irradiation

(2015) John D. Groarke et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Burgeoning Cardio-Oncology Programs

(2015) Tochi M. Okwuosa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group

(2015) Saro H Armenian et al.   LANCET ONCOLOGY

Smoking and Mortality — Beyond Established Causes

(2015) Brian D. Carter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Influence of 1 year of androgen deprivation therapy on lipid and glucose metabolism and fat accumulation in Japanese patients with prostate cancer

(2015) K Mitsuzuka et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Androgen Deprivation Therapy Reversibly Increases Endothelium-Dependent Vasodilation in Men With Prostate Cancer

(2015) P. L. Nguyen et al.   Journal of the American Heart Association

Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming

(2015) Veronica Martinez-Marignac et al.   Oncotarget

Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer

(2014) David R. Ziehr et al.   BJU INTERNATIONAL

Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus

(2014) Keiko Ono et al.   INTERNAL MEDICINE

Prevention of Anthracycline-Induced Cardiotoxicity

(2014) Pimprapa Vejpongsa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

(2014) Giulio Genovese et al.   NEW ENGLAND JOURNAL OF MEDICINE

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

(2014) Siddhartha Jaiswal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of Carotid Angioplasty and Stenting for Radiation-Induced Carotid Stenosis

(2014) Simon C.H. Yu et al.   STROKE

Treatment Techniques to Reduce Cardiac Irradiation for Breast Cancer Patients Treated with Breast-Conserving Surgery and Radiation Therapy: A Review

(2014) Robert E. Beck et al.   Frontiers in Oncology

Cardiotoxicity With 5-Fluorouracil Based Agents: Rechallenge Cannot Currently Be Safely Advised

(2013) Jonathan R. Dalzell et al.   AMERICAN JOURNAL OF CARDIOLOGY

Epidemiology of cancer-associated venous thrombosis

(2013) J. F. Timp et al.   BLOOD

Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer

(2013) Arti Parekh et al.   Brachytherapy

Long-Term Survival of Patients With Radiation Heart Disease Undergoing Cardiac Surgery

(2013) Willis Wu et al.   CIRCULATION

Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions

(2013) Steven E. Lipshultz et al.   CIRCULATION

Ideal Cardiovascular Health Is Inversely Associated With Incident Cancer

(2013) Laura J. Rasmussen-Torvik et al.   CIRCULATION

Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies

(2013) Bonnie Ky et al.   CIRCULATION RESEARCH

Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease

(2013) J. D. Groarke et al.   EUROPEAN HEART JOURNAL

Androgen-deprivation Therapy and Diabetes Control Among Diabetic Men with Prostate Cancer

(2013) Nancy L. Keating et al.   EUROPEAN UROLOGY

Assessment of endothelial dysfunction by flow-mediated dilatation in men on long-term androgen deprivation therapy for prostate cancer

(2013) Stephen E. Gilbert et al.   EXPERIMENTAL PHYSIOLOGY

Therapeutic effect of sunitinib malate and its influence on blood glucose concentrations in a patient with metastatic insulinoma

(2013) Jianpeng Chen et al.   Expert Review of Anticancer Therapy

Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia

(2013) Z. Racil et al.   HAEMATOLOGICA

Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer

(2013) Vicente Bruzzaniti et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Expert Consensus for Multi-Modality Imaging Evaluation of Cardiovascular Complications of Radiotherapy in Adults: A Report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography

(2013) Patrizio Lancellotti et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib

(2013) T D Kim et al.   LEUKEMIA

All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study

(2013) C. Vigneau et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

(2013) Robert J. Motzer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer-Drug Discovery and Cardiovascular Surveillance

(2013) John D. Groarke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer

(2013) Sarah C. Darby et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

(2013) J.E. Cortes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Drug attrition during pre-clinical and clinical development: Understanding and managing drug-induced cardiotoxicity

(2013) Nicola Ferri et al.   PHARMACOLOGY & THERAPEUTICS

27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology

(2013) E. R. Nelson et al.   SCIENCE

Coronary Microvascular Pericytes Are the Cellular Target of Sunitinib Malate-Induced Cardiotoxicity

(2013) V. Chintalgattu et al.   Science Translational Medicine

Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives

(2013) Steven M. Bair et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Analysis of the Lipid Profile and Atherogenic Risk during Androgen Deprivation Therapy in Prostate Cancer Patients

(2013) C. Salvador et al.   UROLOGIA INTERNATIONALIS

The Frequency and Severity of Cardiovascular Toxicity From Targeted Therapy in Advanced Renal Cell Carcinoma Patients

(2013) Philip S. Hall et al.   JACC-Heart Failure

Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer

(2012) K E Henson et al.   BRITISH JOURNAL OF CANCER

Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

(2012) Martha L. Louzada et al.   CIRCULATION

Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

(2012) David Montani et al.   CIRCULATION

Neuregulin in Cardiovascular Development and Disease

(2012) Oghenerukevwe Odiete et al.   CIRCULATION RESEARCH

Cholesterol and breast cancer development

(2012) Christiane Danilo et al.   CURRENT OPINION IN PHARMACOLOGY

Impact of Sunitinib Treatment on Blood Glucose Levels in Patients with Metastatic Renal Cell Carcinoma

(2012) J. J. Oh et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

(2012) Edward H. Romond et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiac angiogenic imbalance leads to peripartum cardiomyopathy

(2012) Ian S. Patten et al.   NATURE

Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

(2012) Jorge E. Cortes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fasting Blood Glucose and Lipid Profile Alterations following Twelve-Month Androgen Deprivation Therapy in Men with Prostate Cancer

(2012) Hasan S. Sağlam et al.   TheScientificWorldJOURNAL

Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry

(2012) Gualberto Gussoni et al.   THROMBOSIS RESEARCH

Prostate Cancer, Androgen Deprivation Therapy, Obesity, the Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular Disease

(2011) Andrew Collier et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Dietary cholesterol intake and cancer

(2011) J. Hu et al.   ANNALS OF ONCOLOGY

Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab

(2011) D. Lenihan et al.   ANNALS OF ONCOLOGY

Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications

(2011) Aspasia Soultati et al.   CANCER TREATMENT REVIEWS

Endothelial-derived neuregulin is an important mediator of ischaemia-induced angiogenesis and arteriogenesis

(2011) N. Hedhli et al.   CARDIOVASCULAR RESEARCH

Effects of Novel Angiogenesis Inhibitors for the Treatment of Cancer on the Cardiovascular System

(2011) Babak Nazer et al.   CIRCULATION

Endothelium-Derived Neuregulin Protects the Heart Against Ischemic Injury

(2011) Nadia Hedhli et al.   CIRCULATION

Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer

(2011) Philip J. Saylor et al.   DRUGS

Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction

(2011) Paul L. Nguyen et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer

(2011) Paul L. Nguyen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Incidence and Risk of Congestive Heart Failure in Patients With Renal and Nonrenal Cell Carcinoma Treated With Sunitinib

(2011) Christopher J. Richards et al.   JOURNAL OF CLINICAL ONCOLOGY

High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis

(2011) Russell A. Moore et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

(2011) Luca Gianni et al.   LANCET ONCOLOGY

Reversible Cardiomyopathy Associated with Sunitinib and Sorafenib

(2011) Imran Uraizee et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

(2011) Dennis Slamon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stroke and Anti-VEGF Therapy

(2011) Takashi Ueta et al.   OPHTHALMOLOGY

Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature

(2011) Ingar Seemann et al.   RADIOTHERAPY AND ONCOLOGY

Ischemic Stroke and Transient Ischemic Attack After Head and Neck Radiotherapy

(2011) Chris Plummer et al.   STROKE

Late Effects in the Era of Modern Therapy for Hodgkin Lymphoma

(2011) D. C. Hodgson   Hematology-American Society of Hematology Education Program

Lung Extracellular Superoxide Dismutase Overexpression Lessens Bleomycin-Induced Pulmonary Hypertension and Vascular Remodeling

(2010) Zachary Van Rheen et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006

(2010) D P Cronin-Fenton et al.   BRITISH JOURNAL OF CANCER

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy

(2010) Javid Moslehi et al.   CIRCULATION

Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress

(2010) Vishnu Chintalgattu et al.   JOURNAL OF CLINICAL INVESTIGATION

Understanding Radiation-Induced Vascular Disease⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

(2010) Neal L. Weintraub et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Conditional HIF-1α Expression Produces a Reversible Cardiomyopathy

(2010) Raffi Bekeredjian et al.   PLoS One

Immunomodulatory drugs increase endothelial tissue factor expression in vitro

(2010) Serena Valsami et al.   THROMBOSIS RESEARCH

Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice

(2010) Nicole M Agostino et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents

(2009) Peace Mabeta et al.   ANGIOGENESIS

Antivascular Actions of Microtubule-Binding Drugs

(2009) E. L. Schwartz   CLINICAL CANCER RESEARCH

Fluoropyrimidine-associated cardiotoxicity: revisited

(2009) M Wasif Saif et al.   Expert Opinion On Drug Safety

Endothelial Function in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia

(2009) Donald R. Dengel et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Increased Risk of Stroke and Transient Ischemic Attack in 5-Year Survivors of Hodgkin Lymphoma

(2009) Marie L. De Bruin et al.   JNCI-Journal of the National Cancer Institute

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

(2009) N. L. Keating et al.   JNCI-Journal of the National Cancer Institute

Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome?

(2008) Matthew R. Smith et al.   BJU INTERNATIONAL

Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib

(2008) B Billemont et al.   BRITISH JOURNAL OF CANCER

Nilotinib: A second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia

(2008) David L. DeRemer et al.   CLINICAL THERAPEUTICS

Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry

(2008) D. Imberti et al.   HAEMATOLOGICA

Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients

(2008) Shobha Rani Nalluri et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Preeclampsia-like Syndrome Characterized by Reversible Hypertension and Proteinuria Induced by the Multitargeted Kinase Inhibitors Sunitinib and Sorafenib

(2008) T. V. Patel et al.   JNCI-Journal of the National Cancer Institute

Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis

(2008) N. Ulu et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice

(2008) C. Louvet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Radiation-induced cardiovascular injury

(2008) Jolyon H. Hendry et al.   RADIATION AND ENVIRONMENTAL BIOPHYSICS

Predicting recurrences or major bleeding in cancer patients with venous thromboembolism

(2008) Javier Trujillo-Santos et al.   THROMBOSIS AND HAEMOSTASIS

Vascular complications of selected cancer therapies

(2008) Iyad N Daher et al.   Nature clinical practice. Cardiovascular medicine